Table 2: Baseline demographic and laboratory characteristics of patients (n=96).

Clinical Characteristics and Laboratory Parameters Mean ± SD/ Median N,%
Ages 64.94 ± 17.3 N/A
Number of male (n,%) N/A 58 (60.4)
Diabetes (n,%) N/A 25 (26)
Hypertension (n,%) N/A 20 (20.8)
Anemia (n,%) N/A 53 (55.2)
Blood urea (mmol/l) 10.35 (8.02 – 17.2) N/A
Serum creatinine (µmol/l)
     - Stage I
     - Stage II
     - Stage III		 175 (151 – 243.5)
160.5 (148 – 180.75)
274 (247 – 318)
466 (435 – 547)		 96 (100)
68 (70.8)
21 (21.9)
7 (7.3)
Cause of AKI
     - Sepsis
     - Non-Sepsis		 N/A 55 (57.3)
41 (42.7)
MOF (n,%) N/A 26 (27.1)
Oliguria (n,%) N/A 31 (32.3)
Urine NGAL (ng/ml) 292.97 (135.65 – 691.25) N/A
Duration of ICU stay (days) 9 (5 – 14) N/A
Recovery from AKI (n,%) N/A 69 (71.9)
Non-recovery from AKI (n,%):
     - Mortality
     - CKD		 N/A 27 (29.1)
16 (16.7)
11 (11.4)

AKI: Acute Kidney Injury, MOF: Multiple Organ Failure, NGAL: Neutrophil gelatinase-associated Lipocalin, ICU: Intensive Care Unit, CKD: Chronic Kidney Disease.